These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18422197)

  • 1. [Study on the formulation and process of Da Chuan Xiong Fang pellet by extrusion-spheronization].
    Hong YL; Feng Y; Xu DS; Jiang LH; Yang Y
    Zhong Yao Cai; 2007 Dec; 30(12):1596-600. PubMed ID: 18422197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on extraction and purification of active parts from Da Chuan Xiong Fang for treatment of migraine].
    Hong YL; Feng Y; Xu DS; Liu HJ
    Zhong Yao Cai; 2007 Jun; 30(6):721-3. PubMed ID: 17918447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formulation and process optimization of formula Qiqi pellets prepared by extrusion-spheronization].
    Chen HX; Jia XB; Chen Y; Pan GL; Cheng XD
    Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(22):1862-5. PubMed ID: 17285984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research on formulation process of Yigong capsule].
    Feng C; Cai YL; Ruan JL
    Zhong Yao Cai; 2008 Jan; 31(1):128-30. PubMed ID: 18589764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets.
    Hileman GA; Upadrashta SM; Neau SH
    Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
    Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimization of formulation of Fufang Danshen immediate release tablet by colligation score].
    Hu RF; Zhu JB; Peng DY; Tang JH; Zhou A
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):380-2. PubMed ID: 16711419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on preparation of glycyrrhiza total flavones effective components sustained-release pellets and its properties].
    Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
    Zhong Yao Cai; 2008 Mar; 31(3):434-8. PubMed ID: 18619252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The preparation and the in vitro release of OANO-1 microspheres].
    Yang F; Bi GW; Long XY; Yu ZM; Yang WS; Feng LP
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):992-4. PubMed ID: 16161426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on preparation of refined Xiong-gui sustained release pills].
    Li H; Bian BL; Meng FY; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2005 May; 30(10):747-9. PubMed ID: 16075712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.
    Kulkarni RB; Amin PD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):199-205. PubMed ID: 18302039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of the speed of spheronization on the physical properties and dissolution availability of theophylline minigranules prepared by extrusion-spheronization].
    Rahman L; Gaudy D; Bataille B; Jacob M; Puech A
    J Pharm Belg; 1991; 46(6):389-95. PubMed ID: 1783973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.